Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Calvet

Showing results (141-150 of 291) with videos related to

Pageof 30
Sort By:
Scientific Reports|February 22, 2018
Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney DiseaseJessica Idowu, Trisha Home, Nisha Patel, et al.
American Journal of Physiology. Renal Physiology|August 4, 2012
Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathwaysKyle Jansson, Anh-Nguyet T Nguyen, Brenda S Magenheimer, et al.
The Journal of Biological Chemistry|August 15, 2006
Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expressionZhousheng Xiao, Shiqin Zhang, Josh Mahlios, et al.
The Journal of Biological Chemistry|October 7, 2004
Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathwaySanjeev Puri, Brenda S Magenheimer, Robin L Maser, et al.
Oncogene|January 27, 2025
Correction: Targeting the vasopressin type-2 receptor for renal cell carcinoma therapySonali Sinha, Nidhi Dwivedi, Shixin Tao, et al.
Oncogene|October 17, 2019
Targeting the vasopressin type-2 receptor for renal cell carcinoma therapySonali Sinha, Nidhi Dwivedi, Shixin Tao, et al.
PPAR Research|June 6, 2012
Global Gene Expression Profiling in PPAR-γ Agonist-Treated Kidneys in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney DiseaseDaisuke Yoshihara, Masanori Kugita, Tamio Yamaguchi, et al.
Developmental Biology|April 24, 2002
Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27(kip1) expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasiaAric W Ledford, Jennifer G Brantley, Gabor Kemeny, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 7, 2021
Quinomycin A reduces cyst progression in polycystic kidney diseasePriyanka S Radadiya, Mackenzie M Thornton, Emily A Daniel, et al.
Journal of the American Society of Nephrology : JASN|November 17, 2006
Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilationBrenda S Magenheimer, Patricia L St John, Kathryn S Isom, et al.
Pageof 30

Showing results (141-150 of 291) with videos related to

Sort By:
Pageof 30
Scientific Reports|February 22, 2018
Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney DiseaseJessica Idowu, Trisha Home, Nisha Patel, et al.
American Journal of Physiology. Renal Physiology|August 4, 2012
Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathwaysKyle Jansson, Anh-Nguyet T Nguyen, Brenda S Magenheimer, et al.
The Journal of Biological Chemistry|August 15, 2006
Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expressionZhousheng Xiao, Shiqin Zhang, Josh Mahlios, et al.
The Journal of Biological Chemistry|October 7, 2004
Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathwaySanjeev Puri, Brenda S Magenheimer, Robin L Maser, et al.
Oncogene|January 27, 2025
Correction: Targeting the vasopressin type-2 receptor for renal cell carcinoma therapySonali Sinha, Nidhi Dwivedi, Shixin Tao, et al.
Oncogene|October 17, 2019
Targeting the vasopressin type-2 receptor for renal cell carcinoma therapySonali Sinha, Nidhi Dwivedi, Shixin Tao, et al.
PPAR Research|June 6, 2012
Global Gene Expression Profiling in PPAR-γ Agonist-Treated Kidneys in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney DiseaseDaisuke Yoshihara, Masanori Kugita, Tamio Yamaguchi, et al.
Developmental Biology|April 24, 2002
Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27(kip1) expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasiaAric W Ledford, Jennifer G Brantley, Gabor Kemeny, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 7, 2021
Quinomycin A reduces cyst progression in polycystic kidney diseasePriyanka S Radadiya, Mackenzie M Thornton, Emily A Daniel, et al.
Journal of the American Society of Nephrology : JASN|November 17, 2006
Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilationBrenda S Magenheimer, Patricia L St John, Kathryn S Isom, et al.
Pageof 30